Luke Nathaniel Walker's Insider Trades & SAST Disclosures

Luke Nathaniel Walker's most recent trade in Zentalis Pharmaceuticals Inc was a trade of 14,200 Common Stock done at an average price of $1.8 . Disclosure was reported to the exchange on Jan. 31, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Zentalis Pharmaceuticals Inc
Luke Nathaniel Walker Director Purchase of securities on an exchange or from another person at price $ 1.76 per share. 31 Jan 2025 14,200 86,681 - 1.8 24,966 Common Stock
Context Therapeutics Inc
Luke Nathaniel Walker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Sep 2024 19,315 19,315 - - Stock Option (right to buy)
Zentalis Pharmaceuticals Inc
Luke Nathaniel Walker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2024 72,481 72,481 - 0 Common Stock
Harpoon Therapeutics Inc
Luke Nathaniel Walker Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2024 115,000 135,000 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades